Induction of tolerance to transplantation antigens is believed to be a prom
ising way to achieve long-term allograft survival without a deleterious imm
unosuppressive regimen. T-cell activation, which is an essential feature of
graft I ejection, requires a first signal provided by T-cell receptor (TCR
) ligation and a second signal provided by engagement of co-stimulatory mol
ecules with their respective ligands on antigen-presenting cells. The coord
inated triggering of these two independent signalling systems ensures the f
ull T-cell activation, including proliferation and acquisition of effector
function. TCR occupancy in the absence of co-stimulator signals leads to a
sustained loss of antigen responsiveness called clonal anergy which could b
e of major importance in transplantation. In vivo, co stimulation blockade
was indeed shown to allow for long-term allograft survival in several trans
plantation models. However, the current continuous identification of new co
-stimulatory molecules suggests that a functional redundancy of the system
exists and that tolerance to transplantation antigens might be achieve ed m
ore easily through the combined blockade of two or several co-stimulatory s
ignals.
In this review we analyse the biological effects of the disruption of some
co-stimulation pathways in vitro and in vivo and discuss their potential in
terest for tolerance induction.